The CDC declared the end of its emergency response to H5N1 avian flu as a health threat to humans, David Murray writes.

The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.

Moderna MRNA announced that its seasonal influenza vaccine candidate, mRNA-1010, achieved superior relative vaccine efficacy (rVE) than an approved flu shot marketed by GSK plc GSK in a phase III ...

The Trump administration recently canceled $766 million in contracts with Moderna to develop and produce an mRNA vaccine against pandemic influenza viruses, including H5N1 avian flu.

REUTERS — The U.S. Centers for Disease Control and Prevention has ended its emergency response for H5N1 avian flu, owing to a decline in animal infections and no reports of human cases since February.

The administration in May canceled a contract awarded to Moderna for the late-stage development of its bird flu vaccine for humans.

The letter highlights HHS’s May 28, 2025, cancellation of a $766 million contract with Moderna for developing vaccines against future pandemic influenza strains, including bird flu.